CIP Dining Series: FDA Readiness as a Valuation Multiplier

DA Readiness as a Valuation Multiplier | CIP Impact Dining Series (with Michel Moravia)

📅 Tuesday, Sept 23, 2025 | 🕠 6:00 – 8:30 PM📍 Waltham, MA |(easy parking)🍽️ Private Dinner | 👥 Limited to 12 Guests

💡 Why This Dinner MattersIn MedTech, clinical milestones and market size often dominate the conversation. But the real multiplier for valuation is FDA readiness.

A strong regulatory strategy doesn’t just accelerate approvals — it builds investor confidence, unlocks funding, and increases company value.

This evening will feature Michel E. Moravia, MBA, MSE — CEO of Quality Means Business (QMB, Inc.), a “40 Under 40” life science leader, and MedTech regulatory innovator. Michel will share real-world cases showing how proactive FDA strategy can change the trajectory of startups and portfolios alike.

👥 Attendance is CuratedPriority will be given to:

• Founders of MedTech or Digital Health startups preparing for fundraising or regulatory submissions
• Investors seeking to de-risk and strengthen their portfolio companies(Select seats may be available for advisors and partners directly supporting these journeys.)

🌟 What to Expect

• Curated Conversation: Small group, meaningful access — not a large panel or mixer
• Practical Insight: Strategies that connect FDA readiness with valuation
• Premium Experience: Fine dining setting in Waltham, designed for thoughtful exchange

🎟 RegistrationLimited to 12 seats. Applications are reviewed on a rolling basis. Venue details will be shared upon confirmation.

✨ CIP Impact Dining Series is hosted by Cambridge Innovation Partners, with the support of TopContenders and MZ Services Inc., as part of our mission to connect founders, investors, and innovators.

📸 Photo/Media DisclaimerPhotos or video may be captured during the event. By attending, you grant permission for use in future outreach and documentation.

Host or Publisher Boston Artificial Intelligence Forum (BAI)